Moderna (MRNA) Tax Rate Growth (1y) (2019 - 2026)

Moderna (MRNA) Tax Rate Growth (1y) (2019 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,801.52 Bn 66,801.23 Bn -
2 Nanobiotix 1,908.00 Bn 1,907.94 Bn -
3 Akari Therapeutics 959.56 Bn 959.56 Bn -
4 BeOne Medicines 472.27 Bn 467.47 Bn 1.35 Bn
5 Vertex Pharmaceuticals 122.18 Bn 114.93 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 70.08 Bn 61.32 Bn 3.31 Bn
7 Belite Bio 62.34 Bn 62.34 Bn -
8 Argenx Se 55.86 Bn 50.68 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.50 Bn 34.49 Bn 959.66 Mn
10 Moderna 21.93 Bn 16.72 Bn -566.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 5.00
Dec 31, 2025 -878.00
Sep 30, 2025 -4,505.00
Mar 31, 2025 13.00
Dec 31, 2024 21,541.00
Sep 30, 2024 12,349.00
Mar 31, 2024 -12,676.00
Dec 31, 2023 -22,148.00
Sep 30, 2023 -9,969.00
Jun 30, 2023 990.00
Mar 31, 2023 11,238.00
Dec 31, 2022 146.00
Sep 30, 2022 813.00
Jun 30, 2022 196.00
Mar 31, 2022 1,043.00
Dec 31, 2021 1,076.00
Sep 30, 2021 660.00
Dec 31, 2020 -112.00
Sep 30, 2020 -58.00
Dec 31, 2019 50.00